Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

Taking dutasteride for one month before prostate surgery can reduce bleeding.

Serum triglyceride levels are not linked to prostate cancer risk.

Male pattern baldness may be linked to prostate cancer risk.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

Antioxidants can block the cancer-fighting effects of doxorubicin.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Vertex pattern hair loss linked to higher prostate cancer risk.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

Minoxidil increases calcium levels and kills prostate cancer cells independently of calcium.

Computational methods help design drugs targeting prostate cancer proteins.

Certain natural compounds called terpenes may help prevent prostate cancer.

Taking finasteride before surgery reduces blood loss in prostate procedures.

5α-reductase inhibitors may help with prostate cancer but could increase the risk of severe tumors, so careful use is advised.

No link was found between hair patterns and prostate cancer risk in South Indian men.

Artocarpus heterophyllus seed extract may help treat prostate inflammation without side effects.

Certain plasma proteins are linked to prostate cancer risk and could help in early detection and treatment.

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.

Dutasteride is more cost-effective than finasteride for treating benign prostatic hyperplasia in Montenegro.

Certain genetic markers may increase or decrease prostate cancer risk.